Company Description

Avalo Therapeutics, formerly Cerecor & Aevi Genomic, is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases.